To validate the predictive capacity of KLF5 in tumor immunotherapy, we performed ROC analysis of pan-cancer immunotherapy cohorts from the GEO database, demonstrating its modest predictive efficacy for immunotherapeutic response (Figure 7B). This evidence concerns the gene KLF5 and cancer.